SBI Holdings, Inc. SBI Holdings, Inc.

SBI Holdings, Inc.

8473

Rangering i aksjer #1687
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online... SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Aksjekurs
$19.65
Markedsverdi
$12.70B
Endring (1 dag)
1.35%
Endring (1 år)
-11.82%
Land
JP
Handel SBI Holdings, Inc. (8473)

Kategori

Financial Services
P/E-forhold for SBI Holdings, Inc. (8473)
P/E-forhold per October 2026 TTM: 3.95
Ifølge SBI Holdings, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 3.95. Ved slutten av 2024 hadde selskapet en P/E på 12.01.
P/E-forholdshistorikk for SBI Holdings, Inc. fra 2005 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) 3.95 -46.87%
2025 7.43 -38.13%
2024 12.01 -38.73%
2023 19.60 847.49%
2022 2.07 -76.57%
2021 8.83 -8.70%
2020 9.67 -18.92%
2019 11.93 -3.49%
2018 12.36 26.91%
2017 9.74 37.02%
2016 7.11 3.08%
2015 6.89 -45.11%
2014 12.56 -76.55%
2013 53.56 -0.19%
2012 53.66 20.98%
2011 44.36 -66.27%
2010 131.51 -1,690.59%
2009 -8.27 -112.99%
2008 63.67 475.51%
2007 11.06 -16.72%
2006 13.28 21.88%
2005 10.90 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.